Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Benzbromarone associated hepatotoxicity

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: TING, Yi-chin (Division of Pharmacy, Cheng Hsin Rehabilitation Medical Center, Taipei, China Taiwan)
  • Co-author(s): Chang, Hung-Chuan (Division of Pharmacy, Cheng Hsin Rehabilitation Medical Center, TAIPEI, China Taiwan)
    Kuo, Chien-Wen (Division of Pharmacy, Cheng Hsin Rehabilitation Medical Center, TAIPEI, China Taiwan)
    Huang, Chien-Ming (Division of Pharmacy, Cheng Hsin Rehabilitation Medical Center, TAIPEI, China Taiwan)
  • Abstract:

    AIMS: Benzbromarone, a widely used uricosuric medication in Taiwan, was withdrawn in many countries due to its hepatotoxicity. In this study, we are objected to assess if there was any benzbromarone associated hepatotoxicity in our hospital. .

    METHODS: A retrospective study was undertaken at Cheng Hsin Rehabilitation Medical Center (Taipei,..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses